|
US3109843A
(en)
|
|
1963-11-05 |
|
Process for preparing |
|
US3102116A
(en)
|
|
1963-08-27 |
|
Process for the purification of y-chloeo- |
|
US3136815A
(en)
|
1959-12-10 |
1964-06-09 |
Hoffmann La Roche |
Amino substituted benzophenone oximes and derivatives thereof
|
|
US3371085A
(en)
|
1959-12-10 |
1968-02-27 |
Hoffmann La Roche |
5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
|
|
US3340253A
(en)
|
1962-11-28 |
1967-09-05 |
Hoffmann La Roche |
Preparation of certain benzodiazepine compounds
|
|
US3243427A
(en)
|
1962-06-21 |
1966-03-29 |
Hoffmann La Roche |
Certain 5-phenyl-1, 2-dihydro (or 1, 2, 4, 5-tetrahydro)-3h-1, 4,-benzodiazepine compounds and their production
|
|
US3374225A
(en)
|
1963-03-28 |
1968-03-19 |
Hoffmann La Roche |
Aminobenzodiazepine compounds and methods
|
|
NL298071A
(cg-RX-API-DMAC10.html)
|
1963-06-04 |
|
|
|
|
GB1051795A
(cg-RX-API-DMAC10.html)
|
1964-02-11 |
|
|
|
|
US3567710A
(en)
|
1968-06-03 |
1971-03-02 |
Hoffmann La Roche |
Process for the preparation of 1,3-dihydro-2h-1,4-benzodiazepin-2-ones
|
|
US3547828A
(en)
|
1968-09-03 |
1970-12-15 |
Rohm & Haas |
Alkyl oligosaccharides and their mixtures with alkyl glucosides and alkanols
|
|
US3609145A
(en)
|
1969-01-10 |
1971-09-28 |
Upjohn Co |
1h-1,4-benzodiazepine-1-sulfonamides
|
|
US3987052A
(en)
|
1969-03-17 |
1976-10-19 |
The Upjohn Company |
6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
|
|
US3722371A
(en)
|
1970-03-12 |
1973-03-27 |
Pneumo Dynamics Corp |
High ratio linkage mechanism
|
|
GB1355998A
(en)
|
1970-09-30 |
1974-06-12 |
Unilever Ltd |
Builders for detergent compositions
|
|
US3949072A
(en)
|
1971-03-11 |
1976-04-06 |
Tenta Louis T |
Topical composition for treatment of seborrheic keratosis
|
|
US4280957A
(en)
|
1974-09-11 |
1981-07-28 |
Hoffmann-La Roche Inc. |
Imidazodiazepines and processes therefor
|
|
US4130709A
(en)
|
1977-12-08 |
1978-12-19 |
Eli Lilly And Company |
Pleuromutilin glycoside derivatives
|
|
JPS57128634A
(en)
|
1981-02-03 |
1982-08-10 |
Eisai Co Ltd |
Elastase-containing compound increasing absorption
|
|
US4440675A
(en)
|
1981-08-18 |
1984-04-03 |
Meloy Laboratories, Inc. |
Human immune interferon
|
|
US4608278A
(en)
|
1983-06-22 |
1986-08-26 |
The Ohio State University Research Foundation |
Small particule formation and encapsulation
|
|
AU570998B2
(en)
|
1983-09-07 |
1988-03-31 |
Takeda Chemical Industries Ltd. |
Topical steroid compositions for acne
|
|
JPS60208911A
(ja)
*
|
1984-03-28 |
1985-10-21 |
Green Cross Corp:The |
ジアゼパム直腸投与製剤
|
|
US4826689A
(en)
|
1984-05-21 |
1989-05-02 |
University Of Rochester |
Method for making uniformly sized particles from water-insoluble organic compounds
|
|
JPS61267528A
(ja)
|
1984-11-26 |
1986-11-27 |
Yamanouchi Pharmaceut Co Ltd |
吸収促進剤を含有するカルシトニン経鼻剤
|
|
DE3444958A1
(de)
|
1984-12-10 |
1986-06-12 |
Henkel KGaA, 4000 Düsseldorf |
Verwendung von alkylglykosiden als potenzierungsmittel in antiseptischen mitteln sowie desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung
|
|
DK17685D0
(da)
|
1985-01-14 |
1985-01-14 |
Hans Goeran Magnusson |
Glycosidderivater
|
|
US5192528A
(en)
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
|
CA1338736C
(fr)
|
1986-12-05 |
1996-11-26 |
Roger Baurain |
Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
|
|
FR2608988B1
(fr)
|
1986-12-31 |
1991-01-11 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
|
|
US5550220A
(en)
|
1987-05-13 |
1996-08-27 |
Curtice-Burns, Inc. |
Alkyl glycoside fatty acid polyester fat substitute food compositions and process to produce the same
|
|
US4921838A
(en)
|
1987-06-16 |
1990-05-01 |
Trustees Of Boston University |
Angiogenic and blood perfusion inducing properties of amphiphilic compounds
|
|
JPH01151528A
(ja)
|
1987-12-08 |
1989-06-14 |
Taiho Yakuhin Kogyo Kk |
経粘膜吸収促進剤
|
|
JPH076254Y2
(ja)
|
1988-03-31 |
1995-02-15 |
株式会社淀川製鋼所 |
分割式横架材を用いた構造体の組付構造および屋根の取付構造
|
|
EP0396777A4
(en)
|
1988-11-14 |
1991-03-13 |
Otsuka Pharmaceutical Co., Ltd. |
Interferon preparation for nasal administration
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
US5182258A
(en)
|
1989-03-20 |
1993-01-26 |
Orbon Corporation |
Systemic delivery of polypeptides through the eye
|
|
US5122187A
(en)
|
1989-06-22 |
1992-06-16 |
Xerox Corporation |
Hot melt ink compositions
|
|
FR2651680B1
(fr)
|
1989-09-14 |
1991-12-27 |
Medgenix Group Sa |
Nouveau procede de preparation de microparticules lipidiques.
|
|
US6482516B1
(en)
|
1993-07-20 |
2002-11-19 |
Banner Pharmacaps, Inc. |
Enrobed tablet
|
|
US5198420A
(en)
|
1989-10-02 |
1993-03-30 |
The General Hospital Corporation |
Use of mullerian inhibiting substance and its agonists and antagonists in the treatment of respiratory distress syndrome
|
|
US5188837A
(en)
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
|
US5369095A
(en)
|
1990-02-14 |
1994-11-29 |
Alcon Laboratories, Inc. |
Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
DK0532546T3
(da)
*
|
1990-05-10 |
1998-12-28 |
Nycomed Pharma As |
Farmaceutisk præparat indeholdende N-glycofuroler og N-ethylenglycoler
|
|
US5252318A
(en)
|
1990-06-15 |
1993-10-12 |
Allergan, Inc. |
Reversible gelation compositions and methods of use
|
|
WO1992000310A1
(en)
|
1990-06-27 |
1992-01-09 |
Dainippon Ink & Chemicals, Inc. |
Alkylated oligosaccharide and acetyl derivative thereof
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
DE69214346T2
(de)
|
1991-05-16 |
1997-03-06 |
Kao Corp |
Gegen mikrobielle Aktivität stabile wässerige Alkylglycosidlösung
|
|
US5317010A
(en)
|
1991-10-10 |
1994-05-31 |
Peter K. T. Pang |
Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
|
|
US5236707A
(en)
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
|
US5457100A
(en)
|
1991-12-02 |
1995-10-10 |
Daniel; David G. |
Method for treatment of recurrent paroxysmal neuropsychiatric
|
|
US5308531A
(en)
|
1992-08-31 |
1994-05-03 |
Henkel Corporation |
Pine-oil containing hard surface cleaning composition
|
|
WO1994005262A1
(en)
|
1992-09-10 |
1994-03-17 |
F.H. Faulding & Co. Limited |
Sustained release matrix composition
|
|
DK0679088T3
(da)
|
1992-09-29 |
2002-10-28 |
Inhale Therapeutic Syst |
Pulmonal levering af aktive fragmenter af parathyreoideaea hormon
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
WO1994020116A1
(en)
|
1993-03-10 |
1994-09-15 |
University Of Alabama Research Foundation |
Artificial primers for glycogen synthesis
|
|
US5661130A
(en)
|
1993-06-24 |
1997-08-26 |
The Uab Research Foundation |
Absorption enhancers for drug administration
|
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
|
US5510264A
(en)
|
1993-09-28 |
1996-04-23 |
Insight Biotech Inc. |
Antibodies which bind meningitis related homologous antigenic sequences
|
|
CA2174324A1
(en)
|
1993-10-21 |
1995-04-27 |
Katsuya Mukae |
Pernasal composition and pernasal preparation containing the same
|
|
GB9409778D0
(en)
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
|
US5556940A
(en)
|
1994-06-20 |
1996-09-17 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
US5955425A
(en)
|
1996-08-02 |
1999-09-21 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
SE9403846D0
(sv)
|
1994-11-09 |
1994-11-09 |
Univ Ohio State Res Found |
Small particle formation
|
|
SE9404196D0
(sv)
|
1994-12-02 |
1994-12-02 |
Astra Ab |
New antithrombotic formulation
|
|
JP4155594B2
(ja)
|
1994-12-22 |
2008-09-24 |
アストラゼネカ・アクチエボラーグ |
エアゾール製剤
|
|
SE9404468D0
(sv)
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
|
US5662883A
(en)
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
|
US5665331A
(en)
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
|
US5716642A
(en)
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
|
US5560932A
(en)
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
CA2218503C
(en)
|
1995-04-20 |
2001-07-24 |
Pfizer Inc. |
Arylsulfonyl hydroxamic acid derivatives
|
|
US20030118594A1
(en)
|
1995-06-07 |
2003-06-26 |
Bishwajit Nag |
Stable formulations of mhc-peptide complexes
|
|
US6143211A
(en)
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
|
US6852690B1
(en)
|
1995-08-22 |
2005-02-08 |
Amylin Pharmaceuticals, Inc. |
Method and composition for enhanced parenteral nutrition
|
|
ES2306452T3
(es)
|
1995-10-17 |
2008-11-01 |
Jagotec Ag |
Aporte de farmacos insolubles.
|
|
US5914332A
(en)
|
1995-12-13 |
1999-06-22 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
|
DK0780386T3
(da)
|
1995-12-20 |
2003-02-03 |
Hoffmann La Roche |
Matrixmetalloproteaseinhibitorer
|
|
US6254854B1
(en)
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
|
AU3207297A
(en)
|
1996-07-01 |
1998-01-21 |
Pharmacia & Upjohn Company |
Process for the production of 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo{1,5-a}benzod iazepine
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
|
EP0922030A1
(en)
|
1996-08-23 |
1999-06-16 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US6077864A
(en)
|
1997-01-06 |
2000-06-20 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
HUP0000852A2
(hu)
|
1997-02-03 |
2001-05-28 |
Pfizer Products Inc. |
Aril-szulfonil-amino-hidroxámsav-származékok, valamint e vegyületeket tartalmazó gyógyászati készítmények
|
|
US6461591B1
(en)
|
1997-02-05 |
2002-10-08 |
Jago Research Ag |
Medical aerosol formulations
|
|
JP2000507975A
(ja)
|
1997-02-07 |
2000-06-27 |
ファイザー・インク |
Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
|
|
NZ336836A
(en)
|
1997-02-11 |
2001-02-23 |
Pfizer |
Arylsulfonyl hydroxamic acid derivatives suitable for a broad range of medicinal treatments
|
|
US20050004049A1
(en)
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
|
US6245760B1
(en)
|
1997-05-28 |
2001-06-12 |
Aventis Pharmaceuticals Products, Inc |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
WO1999001579A1
(en)
|
1997-07-01 |
1999-01-14 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the delivery of oligonucleotides via the alimentary canal
|
|
TR200000368T2
(tr)
|
1997-08-08 |
2000-07-21 |
Pfizer Products Inc. |
Ariloksiariarilsülfonilamino hidroksamik asit türevleri.
|
|
US6165484A
(en)
|
1997-08-26 |
2000-12-26 |
Wake Forest University |
EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections
|
|
US20040141923A1
(en)
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
|
US20050002867A1
(en)
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
MY120063A
(en)
|
1997-12-09 |
2005-08-30 |
Lilly Co Eli |
Stabilized teriparatide solutions
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
AU716724B2
(en)
|
1998-03-26 |
2000-03-02 |
Morton International, Inc. |
A latent mercaptan as a heat stabilizer
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
TWI223598B
(en)
|
1998-06-22 |
2004-11-11 |
Pfizer Ireland Pharmaceuticals |
An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
|
|
ITMI981528A1
(it)
|
1998-07-03 |
2000-01-03 |
Recordati Ind Chimica E Farma |
Formulazioni topiche di aciclovir
|
|
AU6283299A
(en)
|
1998-10-01 |
2000-04-17 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US6608073B1
(en)
|
1998-10-14 |
2003-08-19 |
New Millennium Pharmaceutical Research, Inc. |
Intranasal codeine for the rapid suppression of cough and rapid relief of pain
|
|
EP1004578B1
(en)
|
1998-11-05 |
2004-02-25 |
Pfizer Products Inc. |
5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
|
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
|
US20030087820A1
(en)
|
1999-01-14 |
2003-05-08 |
Young Andrew A. |
Novel exendin agonist formulations and methods of administration thereof
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6495498B2
(en)
|
1999-05-27 |
2002-12-17 |
Johnson & Johnson Consumer Companies, Inc. |
Detergent compositions with enhanced depositing, conditioning and softness capabilities
|
|
GB9912961D0
(en)
|
1999-06-03 |
1999-08-04 |
Pfizer Ltd |
Metalloprotease inhibitors
|
|
CA2379365C
(en)
|
1999-07-26 |
2009-11-17 |
Sk Corporation |
Transnasal anticonvulsive compositions and modulated process
|
|
US7144574B2
(en)
|
1999-08-27 |
2006-12-05 |
Maxygen Aps |
Interferon β variants and conjugates
|
|
US6316410B1
(en)
|
1999-09-22 |
2001-11-13 |
National Research Council Of Canada |
Parathyroid hormone analogues for the treatment of osteoporosis
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
CN1303674A
(zh)
*
|
1999-12-02 |
2001-07-18 |
山东省医药工业研究所 |
阿普唑仑鼻喷剂
|
|
WO2001041782A2
(en)
|
1999-12-09 |
2001-06-14 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
|
WO2001051030A1
(en)
|
2000-01-10 |
2001-07-19 |
Dura Pharmaceuticals, Inc. |
Pharmaceutical formulation and method for pulmonary and oral delivery
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
US7171965B2
(en)
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
|
US6610271B2
(en)
|
2000-05-10 |
2003-08-26 |
University Of Kentucky Research Foundation |
System and method for intranasal administration of lorazepam
|
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
|
US6818741B2
(en)
|
2000-06-01 |
2004-11-16 |
Clf Medical Technology Acceleration Program, Inc. |
Alpha-fetoprotein peptides and uses therof
|
|
US20040147473A1
(en)
|
2000-11-10 |
2004-07-29 |
Warrell Raymond P. |
Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
|
|
US6595210B2
(en)
|
2000-11-27 |
2003-07-22 |
Unisia Jecs Corporation |
Inhalator for administering powder composition
|
|
EP1343521A2
(en)
|
2000-12-01 |
2003-09-17 |
Battelle Memorial Institute |
Method for the stabilizing biomolecules (e.g. insulin) in liquid formulations
|
|
US6884436B2
(en)
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US6607784B2
(en)
|
2000-12-22 |
2003-08-19 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
GB0102902D0
(en)
|
2001-02-06 |
2001-03-21 |
Innovata Biomed Ltd |
Medicaments
|
|
US6551578B2
(en)
|
2001-02-15 |
2003-04-22 |
Aeropharm Technology Incorporated |
Modulated release particles for aerosol delivery
|
|
US20040176359A1
(en)
|
2001-02-20 |
2004-09-09 |
University Of Kentucky Research Foundation |
Intranasal Benzodiazepine compositions
|
|
US7316819B2
(en)
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
|
WO2003007978A1
(en)
|
2001-06-02 |
2003-01-30 |
Clf Medical Technology Acceleration Program, Inc. |
Alpha-fetoprotein peptides and uses thereof
|
|
CN100350977C
(zh)
|
2001-06-14 |
2007-11-28 |
大塚制药株式会社 |
药物组合物
|
|
GB0116107D0
(en)
*
|
2001-06-30 |
2001-08-22 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical composition
|
|
PT1429731E
(pt)
|
2001-09-19 |
2007-04-30 |
Elan Pharma Int Ltd |
Formulações de insulina nanoparticulada
|
|
JP2005508939A
(ja)
|
2001-10-12 |
2005-04-07 |
エラン ファーマ インターナショナル，リミティド |
即時放出および徐放特性を組み合わせて有する組成物
|
|
WO2003044041A2
(en)
|
2001-11-20 |
2003-05-30 |
Clf Medical Technology Acceleration Program, Inc. |
Alpha-fetoprotein peptides and uses for imaging
|
|
FR2834212B1
(fr)
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
EP1490025B1
(en)
|
2002-03-20 |
2008-02-13 |
Elan Pharma International Limited |
Nanoparticulate compositions of map kinase inhibitors
|
|
CA2486584A1
(en)
|
2002-06-07 |
2003-12-18 |
Waratah Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes
|
|
US20060106227A1
(en)
|
2002-06-13 |
2006-05-18 |
Dr Reddy's Laboratories Limited |
3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
|
|
US6855332B2
(en)
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
|
CA2498931A1
(en)
|
2002-09-16 |
2004-03-25 |
Wyeth |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
|
|
US7166575B2
(en)
|
2002-12-17 |
2007-01-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
|
|
WO2004093917A2
(en)
|
2003-04-22 |
2004-11-04 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of triptans
|
|
US20040258663A1
(en)
|
2003-05-08 |
2004-12-23 |
Nastech Pharmaceutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of interferon alpha
|
|
GB0310919D0
(en)
|
2003-05-13 |
2003-06-18 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
US7696147B2
(en)
|
2003-07-08 |
2010-04-13 |
L'oreal |
Perfume composition
|
|
EP1656102A2
(en)
|
2003-08-21 |
2006-05-17 |
Transoral Pharmaceuticals, Inc. |
Compositions for delivering 5-ht agonists across the oral mucosa and methods of use thereof
|
|
WO2005044234A2
(en)
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
ATE403670T1
(de)
|
2003-12-15 |
2008-08-15 |
Phasys Gmbh M |
Rückgefaltetes membranprotein in monodisperser form
|
|
US20060074025A1
(en)
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
|
GB0400804D0
(en)
|
2004-01-14 |
2004-02-18 |
Innoscience Technology Bv |
Pharmaceutical compositions
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7244709B2
(en)
|
2004-05-10 |
2007-07-17 |
Nastech Pharamecutical Company Inc. |
Compositions and methods for enhanced mucosal delivery of parathyroid hormone
|
|
US7877377B2
(en)
*
|
2004-06-03 |
2011-01-25 |
International Business Machines Corporation |
Dropping tautological predicates from SQL queries for reusability
|
|
PL1768650T3
(pl)
|
2004-06-04 |
2009-01-30 |
Camurus Ab |
Ciekłe formulacje depot
|
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
|
US20110257096A1
(en)
|
2004-08-25 |
2011-10-20 |
Aegis Therapeutics, Inc. |
Compositions for drug administration
|
|
US20060046962A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Absorption enhancers for drug administration
|
|
US20090047347A1
(en)
|
2005-07-29 |
2009-02-19 |
Aegis Therapeutics, Inc. |
Compositions for Drug Administration
|
|
EP1789075A4
(en)
|
2004-08-25 |
2009-07-01 |
Uab Research Foundation |
ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
|
|
US20140162965A1
(en)
|
2004-08-25 |
2014-06-12 |
Aegis Therapeutics, Inc. |
Compositions for oral drug administration
|
|
US9114069B2
(en)
|
2004-08-25 |
2015-08-25 |
Aegis Therapeutics, Llc |
Antibacterial compositions for drug administration
|
|
US8642564B2
(en)
|
2004-08-25 |
2014-02-04 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
US20060046969A1
(en)
|
2004-08-25 |
2006-03-02 |
Aegis Therapeutics Llc |
Antibacterial compositions for drug administration
|
|
RU2413530C9
(ru)
|
2004-11-12 |
2021-05-18 |
Ново Нордиск А/С |
Стабильные препараты инсулинотропных пептидов
|
|
EP2623095A1
(en)
|
2004-11-16 |
2013-08-07 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
PL1848403T3
(pl)
|
2005-01-14 |
2010-09-30 |
Camurus Ab |
Preparaty bioadhezyjne o działaniu miejscowym
|
|
EP2353590A1
(en)
|
2005-02-15 |
2011-08-10 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
|
EP1863511A2
(en)
|
2005-02-23 |
2007-12-12 |
UAB Research Foundation |
Alkyl-glycoside enhanced vaccination
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2007002465A2
(en)
|
2005-06-23 |
2007-01-04 |
Rapid Pharmaceuticals, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
ATE544444T1
(de)
|
2005-10-11 |
2012-02-15 |
Yissum Res Dev Co |
Zusammensetzungen für die nasale abgabe
|
|
US8911751B2
(en)
|
2005-10-11 |
2014-12-16 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compositions for nasal delivery
|
|
EP1951248A4
(en)
*
|
2005-11-14 |
2011-05-25 |
Peter D Winch |
NEW COLORED SOLUTIONS OF INJECTABLE MEDICINAL PRODUCTS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
|
|
DE102006027795A1
(de)
|
2006-06-16 |
2007-12-20 |
Lts Lohmann Therapie-Systeme Ag |
Raucherentwöhnungs-Kombinationswafer
|
|
US7425542B2
(en)
|
2006-06-23 |
2008-09-16 |
Aegis Therapeutics, Inc. |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US7998927B2
(en)
|
2006-06-23 |
2011-08-16 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
US20090326193A1
(en)
|
2006-06-23 |
2009-12-31 |
Aegis Therapeutics Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
TW200824693A
(en)
|
2006-08-28 |
2008-06-16 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of clonazepam and methods of use thereof
|
|
US20080275030A1
(en)
|
2007-01-19 |
2008-11-06 |
Sveinbjorn Gizurarson |
Methods and Compositions for the Delivery of a Therapeutic Agent
|
|
TWM316969U
(en)
|
2007-02-14 |
2007-08-11 |
Jau-Chiuan Jian |
Portable work lamp with two-light-sources-switching function
|
|
CA2723470C
(en)
*
|
2007-05-07 |
2013-12-03 |
Hale Biopharma Ventures, Llc |
Nasal administration of benzodiazepines
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
US20090004281A1
(en)
|
2007-06-26 |
2009-01-01 |
Biovail Laboratories International S.R.L. |
Multiparticulate osmotic delivery system
|
|
WO2009046444A2
(en)
*
|
2007-10-05 |
2009-04-09 |
Mdrna, Inc. |
Formulation for intranasal administration of diazepam
|
|
US20090258865A1
(en)
|
2008-03-28 |
2009-10-15 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
|
US20110038899A1
(en)
*
|
2008-03-28 |
2011-02-17 |
Garry Thomas Gwozdz |
Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents
|
|
KR101517415B1
(ko)
|
2008-05-14 |
2015-05-07 |
에스케이바이오팜 주식회사 |
난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
|
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
|
US8440631B2
(en)
|
2008-12-22 |
2013-05-14 |
Aegis Therapeutics, Llc |
Compositions for drug administration
|
|
US20100203014A1
(en)
|
2009-02-04 |
2010-08-12 |
Aegis Therapeutics Llc |
Zwitterionic buffered acidic peptide and protein formulations
|
|
EP2694076A4
(en)
|
2011-04-01 |
2014-08-27 |
Cpex Pharmaceuticals Inc |
Nasal formulations of benzodiazepine
|
|
PT3415139T
(pt)
|
2011-06-14 |
2022-06-20 |
Neurelis Inc |
Administração de benzodiazepina
|
|
EP2747563A4
(en)
|
2011-08-26 |
2015-06-24 |
Aegis Therapeutics Llc |
COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
|
|
US9192570B2
(en)
|
2013-12-20 |
2015-11-24 |
AntiOP, Inc. |
Intranasal naloxone compositions and methods of making and using same
|